Loading...
Loading...
Dilating drops are among the most frequently used medications in any optometric or ophthalmologic practice, and paraoptometrics instill them dozens of times each day. Understanding the distinction between mydriatics (which dilate the pupil) and cycloplegics (which paralyze accommodation) is fundamental to your role -- it affects which drops you prepare, how long you wait before bringing the patient to the doctor, and what you tell the patient about the effects they will experience.
The CPO and CPOA exams test your knowledge of these agents extensively. You need to know the mechanism of each drug, typical onset times and durations, the clinical indications for each, and the safety considerations -- particularly the risk of angle-closure glaucoma. This article covers all of these topics in the depth required for certification.
If you work in a practice that dilates patients, much of this will reinforce what you already do. If you are studying for the exam without extensive clinical experience, focus on the comparison table and the contraindications section, as these are high-yield exam topics.
Mydriatics and cycloplegics affect two different structures in the eye, and understanding the anatomy helps you understand the pharmacology. The iris has two muscles: the sphincter (which constricts the pupil) and the dilator (which dilates the pupil). The ciliary body, located behind the iris, contains the ciliary muscle that controls accommodation -- the process of focusing on near objects by changing the shape of the crystalline lens.
Dilation of the pupil. Achieved by either stimulating the dilator muscle (sympathomimetic) or blocking the sphincter muscle (parasympatholytic). The result is a larger pupil opening that allows the doctor to see the fundus clearly.
Paralysis of the ciliary muscle. Achieved by blocking parasympathetic innervation to the ciliary body. Prevents accommodation, so the eye cannot focus at near. This reveals the true refractive error without the confounding effect of accommodation.
Key Distinction for the Exam
Phenylephrine produces mydriasis WITHOUT cycloplegia (it is a sympathomimetic that stimulates the dilator muscle). All other commonly used dilation drops (tropicamide, cyclopentolate, atropine, homatropine) are parasympatholytics that produce BOTH mydriasis and cycloplegia. This is a frequently tested concept.
Sympathomimetic — Mydriatic Only
Stimulates the alpha-1 adrenergic receptors on the iris dilator muscle, causing pupil dilation without affecting accommodation. Often used in combination with tropicamide for a faster and more complete dilation. The 2.5% concentration is standard; the 10% concentration is rarely used in optometry due to the risk of cardiovascular side effects (hypertension, tachycardia), particularly in elderly patients and infants.
Parasympatholytic — Mydriatic + Mild Cycloplegic
The most commonly used dilation drop in optometric practice. Blocks muscarinic receptors on both the iris sphincter (causing mydriasis) and the ciliary muscle (causing mild cycloplegia). Its popularity comes from its rapid onset, moderate duration, and relatively quick recovery. Patients are typically comfortable within 4-6 hours. The 1% concentration provides stronger mydriasis and is preferred in patients with darkly pigmented irides, who may dilate less readily.
Parasympatholytic — Strong Cycloplegic
The workhorse cycloplegic for cycloplegic refraction. Provides significantly stronger cycloplegia than tropicamide, making it the preferred choice when accurate measurement of the full refractive error is needed -- particularly in children and young adults who have strong accommodative ability. Used routinely for pediatric refractions and when the doctor suspects latent hyperopia. The 1% concentration is most common; 0.5% is used in infants and young children to reduce systemic risk.
Parasympatholytic — Strongest Cycloplegic
The strongest available cycloplegic. Produces complete paralysis of accommodation and maximum dilation. Rarely used for routine dilation because of its extremely long duration -- effects can last 7 to 14 days, during which the patient has significant photophobia and cannot focus at near. Primary uses include amblyopia treatment (penalization therapy), pre-operative evaluations requiring the most accurate refraction possible, and treatment of certain inflammatory conditions (uveitis) where prolonged cycloplegia reduces pain and prevents posterior synechiae.
Parasympatholytic — Moderate Cycloplegic
Falls between cyclopentolate and atropine in strength and duration. Sometimes used when the doctor wants stronger cycloplegia than cyclopentolate provides but does not need the 7-14 day duration of atropine. Also used therapeutically for uveitis to keep the pupil dilated and the ciliary muscle relaxed, reducing pain and preventing the iris from adhering to the lens (posterior synechiae).
| Agent | Mechanism | Mydriasis | Cycloplegia | Onset | Duration |
|---|---|---|---|---|---|
| Phenylephrine 2.5% | Sympathomimetic | Yes | No | 15–30 min | 3–5 hr |
| Tropicamide 1% | Parasympatholytic | Yes | Mild | 20–30 min | 4–6 hr |
| Cyclopentolate 1% | Parasympatholytic | Yes | Strong | 30–60 min | ~24 hr |
| Homatropine 5% | Parasympatholytic | Yes | Strong | 30–60 min | 1–3 days |
| Atropine 1% | Parasympatholytic | Yes | Maximum | 30–40 min | 7–14 days |
The most common use. Tropicamide 1% alone or in combination with phenylephrine 2.5% is instilled to dilate the pupil so the doctor can examine the retina, optic nerve, lens, and vitreous with a binocular indirect ophthalmoscope (BIO) or through the slit lamp with a condensing lens. The combination approach provides faster and more complete dilation. This is typically done during comprehensive eye exams and for patients with specific conditions like diabetes that require regular fundus evaluation.
When the doctor needs to know the patient's refractive error without the influence of accommodation. This is essential in children, who have powerful accommodative ability and can mask significant hyperopia during a standard refraction. In a child who accommodates 3 diopters during the exam, the result without cycloplegia would underestimate their hyperopia by that amount. Cyclopentolate is the standard agent for cycloplegic refraction; atropine is used when cyclopentolate is not sufficient (very young children, darkly pigmented irides, or when previous cyclopentolate refraction was unreliable).
Atropine penalization uses 1% atropine in the better-seeing eye to blur its near vision, forcing the brain to use the weaker amblyopic eye. This is prescribed as an at-home treatment, typically one drop on weekends or daily depending on the severity and protocol. It is an evidence-based alternative to patching that some families prefer for compliance reasons. The paraoptometric should understand this use because parents will ask questions about the treatment schedule and expected effects.
In anterior uveitis (iritis), cycloplegic drops serve two therapeutic purposes: they relax the ciliary muscle to reduce pain (ciliary spasm is a major source of discomfort in uveitis), and they keep the pupil dilated to prevent the inflamed iris from sticking to the lens (posterior synechiae), which can cause permanent adhesions and pupil irregularity. Atropine or homatropine is typically used because longer-acting agents are preferred in this context.
The most important contraindication. Dilation in patients with narrow angles can precipitate acute angle-closure glaucoma by pushing the peripheral iris into the drainage angle, blocking aqueous outflow. Intraocular pressure rises rapidly, causing pain, nausea, halos around lights, and potential permanent vision loss. Pre-dilation assessment of angle width (van Herick method, gonioscopy, or history review) is mandatory. Never dilate without confirming the patient has been cleared for dilation.
The expected and unavoidable side effects of dilation. A dilated pupil lets in more light than normal, causing discomfort in bright conditions. Cycloplegia prevents near focus, so reading and phone use become difficult. These effects are temporary but can be inconvenient, and patients should be warned before dilation. Providing disposable sunglasses is standard practice.
Phenylephrine is a sympathomimetic that can cause systemic cardiovascular effects, especially at the 10% concentration. These include hypertension, tachycardia, and cardiac arrhythmias. The 2.5% concentration is preferred for this reason. Particular caution is warranted in elderly patients, infants, and patients with cardiovascular disease. Punctal occlusion after instillation helps reduce systemic absorption.
Cyclopentolate and atropine can cause central nervous system effects in young children, including drowsiness, confusion, hallucinations, and behavioral changes. These effects are uncommon but significant. Lower concentrations (cyclopentolate 0.5%) are used in infants and young children to minimize this risk. Parents should be warned to monitor their child after instillation and to contact the office if unusual behavior occurs.
Your daily responsibilities with mydriatics and cycloplegics go beyond instilling the drops. You are the person managing the timing, communicating with the patient, and ensuring safety protocols are followed.
Timing for the Schedule
Know how long each agent takes to reach full effect so you can instill drops at the right time relative to when the doctor will see the patient. If tropicamide takes 20-30 minutes, instill it early enough so the patient is fully dilated when their turn comes.
Pre-Dilation Screening
Follow your office protocol for assessing angle-closure risk. This may include checking the patient's chart for previous dilation history, performing a penlight assessment of anterior chamber depth, or noting the doctor's specific instructions for that patient.
Darkly Pigmented Irides
Patients with dark brown irides often dilate more slowly and less completely than patients with light-colored irides. Additional time, a second drop, or a higher concentration may be needed. Report incomplete dilation to the doctor.
Patient Warnings
Always warn patients about photophobia, blurred near vision, and driving considerations. Provide disposable sunglasses. Tell them specifically how long the effects will last based on the drops used. These warnings reduce callbacks and patient dissatisfaction.
Complete guide to all ophthalmic drop categories used in optometric practice.
Step-by-step technique, documentation requirements, and patient communication.
Systemic medications affecting the eyes and ophthalmic drug interaction concerns.
Browse all CPO and CPOA study topics organized by category.
Mydriasis is dilation of the pupil, which makes the opening larger so the doctor can see into the back of the eye. Cycloplegia is paralysis of the ciliary muscle, which eliminates accommodation (the eye's ability to change focus for near objects). Mydriasis affects the iris muscles; cycloplegia affects the ciliary body. Some drops produce both effects (tropicamide, cyclopentolate, atropine), while phenylephrine produces only mydriasis without significant cycloplegia. This distinction matters clinically because cycloplegic refraction requires cycloplegia, not just mydriasis.
Tropicamide is the most popular dilation drop because it offers the best balance of effectiveness and convenience. It provides good mydriasis and mild cycloplegia, has a relatively quick onset (20-30 minutes), and its effects wear off within 4-6 hours -- meaning the patient is not bothered by blurred vision and light sensitivity for an entire day. Stronger cycloplegics like cyclopentolate (24 hours) or atropine (7-14 days) are reserved for specific situations where their longer duration or stronger cycloplegia is needed.
Dilating a patient with narrow anterior chamber angles carries a risk of precipitating acute angle-closure glaucoma. When the pupil dilates, the iris bunches up at the angle and can block aqueous humor drainage, causing a rapid and dangerous rise in intraocular pressure. This is why pre-dilation screening is essential. The doctor may still choose to dilate a patient with narrow angles if the benefit outweighs the risk, but it requires a specific decision by the doctor -- the paraoptometric should never dilate these patients without explicit authorization and should be prepared to monitor for signs of angle closure afterward.
Atropine penalization is an alternative to patching for amblyopia treatment. A drop of atropine 1% is instilled in the better-seeing (non-amblyopic) eye, typically on weekends or daily depending on the protocol. The atropine causes prolonged cycloplegia in that eye, blurring its near vision and forcing the child to use the weaker (amblyopic) eye for near tasks. This stimulates visual development in the amblyopic eye. Some children and families prefer atropine penalization because it avoids the social stigma and compliance challenges of wearing an eye patch.
Before dilation, inform the patient that: their pupils will become larger and stay dilated for several hours (give a specific timeframe based on the drops used -- 4-6 hours for tropicamide, up to 24 hours for cyclopentolate); they will be sensitive to light and should bring sunglasses or disposable shades will be provided; their near vision will be blurry and they should not plan to do detailed near work immediately after; driving may be affected and they should plan accordingly, especially if they are particularly light-sensitive; and the stinging upon instillation is normal and lasts only a few seconds. This informed communication reduces patient anxiety and complaints.